Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
71,153,743
-
Total 13F shares
-
33,975,369
-
Share change
-
+6,894,013
-
Total reported value
-
$991,041,334
-
Put/Call ratio
-
33%
-
Price per share
-
$29.17
-
Number of holders
-
127
-
Value change
-
+$212,840,448
-
Number of buys
-
97
-
Number of sells
-
29
Institutional Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q2 2020
As of 30 Jun 2020,
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) was held by
127 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,975,369 shares.
The largest 10 holders included
NORWEST VENTURE PARTNERS XI, LP, NORWEST VENTURE PARTNERS XII, LP, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Capital Research Global Investors, ALLIANCEBERNSTEIN L.P., Clearbridge Investments, LLC, JANUS HENDERSON GROUP PLC, and Capital International Investors.
This page lists
125
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.